Saol Therapeutics Revenue and Competitors

Atlanta, GA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Saol Therapeutics's estimated annual revenue is currently $9M per year.(i)
  • Saol Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • Saol Therapeutics has 45 Employees.(i)
  • Saol Therapeutics grew their employee count by -38% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.7M10310%N/AN/A
#2
$12.9M6412%N/AN/A
#3
$9M45-38%N/AN/A
#4
$21.3M1068%N/AN/A
#5
$9M457%N/AN/A
#6
$39.8M198-14%N/AN/A
#7
$0.3M350%$50MN/A
#8
$14.7M73-11%N/AN/A
#9
$8M40-2%N/AN/A
#10
$16.3M813%N/AN/A
Add Company

Saol Therapeutics (pronounced ?Sail??) is a privately held specialty pharmaceutical company focused on providing therapies to patients with rare diseases. The company has a strategic emphasis on the neurology therapeutic area. For more information, please visit our website: www.saolrx.com.

keywords:N/A

N/A

Total Funding

45

Number of Employees

$9M

Revenue (est)

-38%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Saol Therapeutics News

2022-04-20 - Amneal Scores Second US Biosimilar Approval With Avastin ...

Amneal says an $83.5m deal to acquire Saol Therapeutics' baclofen franchise will also bring the firm an “experienced institutional...

2022-03-22 - Saol Therapeutics and GeneDx, Inc. Collaborate to Detect ...

Saol is focused on clinical development activity in rare diseases, with a focus on mitochondrial disorders, as well as central nervous system...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.7M457%N/A
#2
$8.2M45-13%N/A
#3
$12M465%N/A
#4
$15M4628%N/A
#5
$5.3M4615%N/A

Saol Therapeutics Executives


NameTitle
Brian NappiSenior Vice President, Strategy
Brian JennetteVice President Finance
Melinda KoehlerVP, Operations & Compliance